Reshape Lifesciences Inc (RSLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2007 | 03-2007 | |
| Cash Flows From Operating Activities | ||
| Net Income | -12,876 | -5,398 |
| Depreciation Amortization | 508 | 22 |
| Accounts payable and accrued liabilities | -473 | 174 |
| Other Working Capital | -1,161 | -456 |
| Other Operating Activity | 2,359 | 315 |
| Operating Cash Flow | $-11,643 | $-5,343 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | 8,720 | 3,180 |
| PPE Investments | -555 | -271 |
| Investing Cash Flow | $8,165 | $2,910 |
| Cash Flows From Financing Activities | ||
| Change In Short Term Borrowing | 5,000 | N/A |
| Common Stock Issued | 12 | 11 |
| Other Financing Activity | -1,296 | -641 |
| Financing Cash Flow | $3,716 | $-630 |
| Beginning Cash Position | 17,537 | 17,537 |
| End Cash Position | 17,775 | 14,473 |
| Net Cash Flow | $238 | $-3,064 |
| Free Cash Flow | ||
| Operating Cash Flow | -11,643 | -5,343 |
| Capital Expenditure | -555 | -271 |
| Free Cash Flow | -12,199 | -5,614 |